• 1.

    Bertoli A , Greco AV , Caputo S , Caradonna P , Grieco A , Laghi V , 1982. Visceral leishmaniasis presenting with hypertrigliceridaemia. Lancet 320: 504505.

    • Search Google Scholar
    • Export Citation
  • 2.

    Bekaert ED , Dole E , Dubois DY , Bouma M-E , Lontie J-F , Kallel R , Malmendier CL , Ayrault‐Jarrier M , 1992. Alterations in lipoprotein density classes in infantile visceral leishmaniasis: presence of apolipoprotein SAA. Eur J Clin Invest 3: 190199.

    • Search Google Scholar
    • Export Citation
  • 3.

    Mohapatra S , Ramakrishan L , Samantaray J , Dash S , 2014. Lipid derangement as diagnostic and prognostic indicator for visceral leishmaniasis patients. Trop Parasitol 4: 134135.

    • Search Google Scholar
    • Export Citation
  • 4.

    Lal CS et al.2016. Hypertriglyceridemia: a possible diagnostic marker of disease severity in visceral leishmaniasis. Infection 44: 3945.

  • 5.

    Ghosh J , Das S , Guha R , Ghosh D , Naskar K , Das A , Roy S , 2012. Hyperlipidemia offers protection against Leishmania donovani infection: role of membrane cholesterol. J Lipid Res 53: 25602572.

    • Search Google Scholar
    • Export Citation
  • 6.

    Liberopoulos E , Alexandridis G , Bairaktari E , Elisaf M , 2002. Severe hypocholesterolemia with reduced serum lipoprotein(a) in a patient with visceral leishmaniasis. Ann Clin Lab Sci 32: 305308.

    • Search Google Scholar
    • Export Citation
  • 7.

    Coura-Vital W , de Araújo VEM , Reis IA , Amancio FF , Reis AB , Carneiro M , 2014. Prognostic factors and scoring system for death from visceral leishmaniasis: an historical cohort study in Brazil. PLoS Negl Trop Dis 8: e3374.

    • Search Google Scholar
    • Export Citation
  • 8.

    Kämink SS , Collin SM , Harrison T , Gatluak F , Mullahzada AW , Ritmeijer K , 2017. A clinical severity scoring system for visceral leishmaniasis in immunocompetent patients in south Sudan. PLoS Negl Trop Dis 11: e0005921.

    • Search Google Scholar
    • Export Citation
  • 9.

    De Queiroz Sampaio MJA , Cavalcanti NV , Alves JGB , Filho MJCF , Correia JB , 2010. Risk factors for death in children with visceral leishmaniasis. PLoS Negl Trop Dis 11: e877.

    • Search Google Scholar
    • Export Citation
  • 10.

    Araki MVR , Barros C , Santos EG , 2011. Análise do perfil lipídico de crianças e adolescentes do estado de Sergipe. Sci Plena 6: 12b.

  • 11.

    Leao SC , Carvalho TS , Galvão MP , Silva RV , Rocha MF , Queiroz AAF , Almeida RO , Araujo RR , Souto MJS , de Andrade Rodrigues TM , 2016. A decade of lipid profiles: a gender focus. Hear Res - Open J 3: 915.

    • Search Google Scholar
    • Export Citation
  • 12.

    Malmendier CL , Lontie JF , Dubois DY , 1991. Mechanisms of hypocholesterolemia. Adv Exp Med Biol 285: 173182.

  • 13.

    Auerbach BJ , Parks JS , 1989. Lipoprotein abnormalities associated with lipopolysaccharide-induced lecithin: cholesterol acyltransferase and lipase deficiency. J Biol Chem 264: 1026410270.

    • Search Google Scholar
    • Export Citation
  • 14.

    Lal CS , Kumar A , Kumar S , Pandey K , Kumar N , Bimal S , Sinha PK , Das P , 2007. Hypocholesterolemia and increased triglyceride in pediatric visceral leishmaniasis. Clin Chim Acta 382: 151153.

    • Search Google Scholar
    • Export Citation
  • 15.

    Feingold KR , Memon RA , Moser AH , Shigenaga JK , Grunfeld C , 1999. Endotoxin and interleukin-1 decrease hepatic lipase mRNA levels. Atherosclerosis 142: 379387.

    • Search Google Scholar
    • Export Citation
  • 16.

    Patton JS , Shepard HM , Wilking H , Lewis G , Aggarwal BB , Eessalu TE , Gavin LA , Grunfeld C , 1986. Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. Proc Natl Acad Sci USA 83: 83138317.

    • Search Google Scholar
    • Export Citation
  • 17.

    Liberopoulos EN , Apostolou F , Gazi IF , Kostara C , Bairaktari ET , Tselepis AD , Elisaf M , 2014. Visceral leishmaniasis is associated with marked changes in serum lipid profile. Eur J Clin Invest 44: 719727.

    • Search Google Scholar
    • Export Citation
  • 18.

    Wang G et al.2020. Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study. Lipids Health Dis 19: 204.

    • Search Google Scholar
    • Export Citation
  • 19.

    Zhou Y , Chi J , Lv W , Wang Y , 2021. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (COVID-19). Diabetes Metab Res Rev 37: e3377.

    • Search Google Scholar
    • Export Citation
  • 20.

    Luzi L , Radaelli MG , 2020. Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic. Acta Diabetol 57: 759764.

    • Search Google Scholar
    • Export Citation
  • 21.

    Lago AS et al., 2020. Diabetes modifies the clinic presentation of cutaneous leishmaniasis. Open Forum Infect Dis 7: ofaa491.

  • 22.

    Schwetz V et al.2018. Visceral leishmaniasis in a patient with diabetes mellitus type 2 and discrete bicytopenia. Clin Case Rep 6: 7881.

  • 23.

    Sarnáglia GD , Covre LP , Pereira FEL , De Matos Guedes HL , Faria AMC , Dietze R , Rodrigues RR , Maioli TU , Gomes DCO , 2016. Diet-induced obesity promotes systemic inflammation and increased susceptibility to murine visceral leishmaniasis. Parasitology 143: 16471655.

    • Search Google Scholar
    • Export Citation
Past two years Past Year Past 30 Days
Abstract Views 2458 2314 16
Full Text Views 42 27 3
PDF Downloads 48 31 3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 

 

 

Association between Hypertriglyceridemia and Disease Severity in Visceral Leishmaniasis

Mariana Garcez VarelaImmunology and Molecular Biology Laboratory, University Hospital, Federal University of Sergipe (HU-UFS), Aracaju, Sergipe, Brazil;
Endocrinology Service from the University Hospital/EBSERH, Federal University of Sergipe, Aracaju, Sergipe, Brazil;
Heath Science Graduate Program, Aracaju, Brazil;

Search for other papers by Mariana Garcez Varela in
Current site
Google Scholar
PubMed
Close
,
Mariana de Oliveira BezerraImmunology and Molecular Biology Laboratory, University Hospital, Federal University of Sergipe (HU-UFS), Aracaju, Sergipe, Brazil;

Search for other papers by Mariana de Oliveira Bezerra in
Current site
Google Scholar
PubMed
Close
,
Felipe Vieira SantanaImmunology and Molecular Biology Laboratory, University Hospital, Federal University of Sergipe (HU-UFS), Aracaju, Sergipe, Brazil;

Search for other papers by Felipe Vieira Santana in
Current site
Google Scholar
PubMed
Close
,
Marcos Couto GomesImmunology and Molecular Biology Laboratory, University Hospital, Federal University of Sergipe (HU-UFS), Aracaju, Sergipe, Brazil;

Search for other papers by Marcos Couto Gomes in
Current site
Google Scholar
PubMed
Close
,
Pedro Ribeiro de Jesus AlmeidaUniversidade Federal de Minas Gerais (UFMG), Faculdade de Medicina, Belo Horizonte, Minas Gerais, Brazil;

Search for other papers by Pedro Ribeiro de Jesus Almeida in
Current site
Google Scholar
PubMed
Close
,
Geydson Silveira da CruzHeath Science Graduate Program, Aracaju, Brazil;
Hematology Service, University Hospital, Federal University of Sergipe (HU-UFS), Aracaju, Sergipe, Brazil;

Search for other papers by Geydson Silveira da Cruz in
Current site
Google Scholar
PubMed
Close
,
Enaldo Vieira de MeloPediatric Clinic, University Hospital, Federal University of Sergipe (HU-UFS), Aracaju, Sergipe, Brazil;

Search for other papers by Enaldo Vieira de Melo in
Current site
Google Scholar
PubMed
Close
,
Paulo Roberto de Oliveira CostaInfectious Disease Clinic, University Hospital, Federal University of Sergipe (HU-UFS), Aracaju, Sergipe, Brazil;

Search for other papers by Paulo Roberto de Oliveira Costa in
Current site
Google Scholar
PubMed
Close
,
Fabrícia Alvisi de OliveiraImmunology and Molecular Biology Laboratory, University Hospital, Federal University of Sergipe (HU-UFS), Aracaju, Sergipe, Brazil;

Search for other papers by Fabrícia Alvisi de Oliveira in
Current site
Google Scholar
PubMed
Close
,
Amélia Ribeiro de JesusImmunology and Molecular Biology Laboratory, University Hospital, Federal University of Sergipe (HU-UFS), Aracaju, Sergipe, Brazil;
Heath Science Graduate Program, Aracaju, Brazil;
Immunology Investigative Institute, INCT, CNPq, São Paulo, Brazil

Search for other papers by Amélia Ribeiro de Jesus in
Current site
Google Scholar
PubMed
Close
, and
Roque Pacheco de AlmeidaImmunology and Molecular Biology Laboratory, University Hospital, Federal University of Sergipe (HU-UFS), Aracaju, Sergipe, Brazil;
Heath Science Graduate Program, Aracaju, Brazil;
Immunology Investigative Institute, INCT, CNPq, São Paulo, Brazil

Search for other papers by Roque Pacheco de Almeida in
Current site
Google Scholar
PubMed
Close
Restricted access

ABSTRACT.

Visceral leishmaniasis (VL) is a tropical disease endemic to Brazil. The clinical manifestations of the infection range from asymptomatic to severe. In VL, changes in lipid metabolism, such as hypocholesterolemia and hypertriglyceridemia, occur that are believed to be related to its progression and severity. This study investigated the associations between serum levels of cholesterol, triglycerides, and lipoproteins (high-density lipoprotein, low-density lipoprotein, and very low-density lipoprotein) with clinical and hematological parameters that predict severity in a case series of 83 VL patients. Severely ill patients had higher mean serum triglyceride levels than non-severely ill patients. There was a significant positive correlation between disease severity score and serum triglyceride levels, very low-density lipoprotein, international normalized ratio for prothrombin time test, total bilirubin, and age. An inverse correlation was detected between the disease severity score and mean platelet and neutrophil counts. Hypertriglyceridemia can be a prognostic indicator of severity in patients diagnosed with VL.

Author Notes

Address correspondence to Roque Pacheco de Almeida, Laboratório de Imunologia e Biologia Molecular, Hospital Universitário, Rua Claudio Batista, s/n, CEP 49060-100, Aracaju, Brazil. E-mail: roquepachecodealmeida@gmail.com

Authors’ addresses: Mariana Garcez Varela, Immunology and Molecular Biology Laboratory, University Hospital, Federal University of Sergipe (HU-UFS), Aracaju, Sergipe, Brazil, Encrinology Service from the University Hospital/EBSERH, Federal University of Sergipe, Aracaju, Sergipe, Brazil, and Heath Science Graduate Program, Aracaju, Brazil, E-mail: marianagarcezvarela@gmail.com. Mariana de Oliveira Bezerra, Felipe Vieira Santana, Marcos Couto Gomes, and Fabricia Alvisi de Oliveira, Immunology and Molecular Biology Laboratory, University Hospital, Federal University of Sergipe (HU-UFS), Aracaju, Sergipe, Brazil, E-mails: marianao06@hotmail.com, felipevs028@gmail.com, coutogomesmarcos@gmail.com, and fa_alvisi@hotmail.com. Pedro Ribeiro de Jesus Almeida, Universidade Federal de Minas Gerais (UFMG), Faculdade de Medicina, Belo Horizonte, Minas Gerais, Brazil, E-mail: pedrojesus.almeida@gmail.com. Geydson Silveira da Cruz, Heath Science Graduate Program, Aracaju, Brazil, and Hematology Service, University Hospital, Federal University of Sergipe (HU-UFS), Aracaju, Sergipe, Brazil, E-mail: geydson@yahoo.com. Enaldo Vieira de Melo, Pediatric Clinic, University Hospital, Federal University of Sergipe (HU-UFS), Aracaju, Sergipe, Brazil, E-mail: evmsidarta@gmail.com. Paulo Roberto de Oliveira Costa, Infectious Disease Clinic, University Hospital, Federal University of Sergipe (HU-UFS), Aracaju, Sergipe, Brazil, E-mail: paulo_roc@hotmail.com. Amélia Ribeiro de Jesus and Roque Pacheco de Almeida, Immunology and Molecular Biology Laboratory, University Hospital, Federal University of Sergipe (HU-UFS), Aracaju, Sergipe, Brazil, Heath Science Graduate Program, Aracaju, Brazil, and Immunology Investigative Institute, INCT, CNPq, E-mails: ameliaribeirodejesus@gmail.com and roquepachecodealmeida@gmail.com.

Save